These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16215675)

  • 21. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
    Wang P; Song JH; Song DK; Zhang J; Hao C
    Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway.
    Wang S
    Oncogene; 2008 Oct; 27(48):6207-15. PubMed ID: 18931688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
    Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents.
    Garattini E; Gianni' M; Terao M
    Vitam Horm; 2007; 75():301-54. PubMed ID: 17368321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents.
    Rowinsky EK
    J Clin Oncol; 2005 Dec; 23(36):9394-407. PubMed ID: 16361639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin.
    Raju J; Mehta R
    Nutr Cancer; 2009; 61(1):27-35. PubMed ID: 19116873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of apoptosis by cancer chemopreventive agents.
    D'Agostini F; Izzotti A; Balansky RM; Bennicelli C; De Flora S
    Mutat Res; 2005 Dec; 591(1-2):173-86. PubMed ID: 16137721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trials with retinoids for breast cancer chemoprevention.
    Zanardi S; Serrano D; Argusti A; Barile M; Puntoni M; Decensi A
    Endocr Relat Cancer; 2006 Mar; 13(1):51-68. PubMed ID: 16601279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention.
    Niles RM
    Acta Pharmacol Sin; 2007 Sep; 28(9):1383-91. PubMed ID: 17723172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
    J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy.
    Sarkar FH; Li YW
    Acta Pharmacol Sin; 2007 Sep; 28(9):1305-15. PubMed ID: 17723164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.
    Ashkenazi A
    Nat Rev Drug Discov; 2008 Dec; 7(12):1001-12. PubMed ID: 18989337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
    Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
    Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
    Deeb D; Gao X; Dulchavsky SA; Gautam SC
    J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.
    Shi J; Shen HM
    Biochem Pharmacol; 2008 May; 75(9):1729-42. PubMed ID: 18377873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemopreventive effects of natural dietary compounds on cancer development.
    Pan MH; Ho CT
    Chem Soc Rev; 2008 Nov; 37(11):2558-74. PubMed ID: 18949126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis.
    Opel D; Westhoff MA; Bender A; Braun V; Debatin KM; Fulda S
    Cancer Res; 2008 Aug; 68(15):6271-80. PubMed ID: 18676851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of fenretinide-induced apoptosis.
    Hail N; Kim HJ; Lotan R
    Apoptosis; 2006 Oct; 11(10):1677-94. PubMed ID: 16850162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis as a novel target for cancer chemoprevention.
    Sun SY; Hail N; Lotan R
    J Natl Cancer Inst; 2004 May; 96(9):662-72. PubMed ID: 15126603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.